Product Information
AMIKACIN SULF 500 MG/2 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $2.3276 per ML under NDC 63323081502. Its NADAC has been published 76 times since Apr 23, 2025.
FDA first approved this application on Dec 9, 2015. Its Orange Book therapeutic-equivalence code is AP.
Strength
250 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323081502
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
AMIKACIN SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA205604FDA Approved
12/9/2015
TE Code
AP
On Market Since
12/9/2015
Pharmacological Classes
Price Statistics
The NADAC for AMIKACIN SULF 500 MG/2 ML VIAL has been published 76 times since Apr 23, 2025, and over the history we have for it it has declined 23.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3276 per ML |
|---|---|
| All-time high | $3.2069 (Aug 13, 2025) |
| All-time low | $2.2657 (Jul 22, 2026) |
| 52-week high | $3.0332 |
| 52-week low | $2.2657 |
| Median price | $2.7228 |
| Average price | $2.7797 |
| Largest weekly change | -16.7% (Jun 17, 2026) |
| Weeks tracked | 76 |
| Tracking since | Apr 23, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amikacin Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMIKACIN SULF 500 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for AMIKACIN SULF 500 MG/2 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $2.3276 per ML (NDC 63323081502), effective Sep 30, 2026.
How has the price of AMIKACIN SULF 500 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for AMIKACIN SULF 500 MG/2 ML VIAL has declined 23.7%. It has been tracked across 76 weekly CMS publications since Apr 23, 2025.
What are the highest and lowest recorded NADAC prices for AMIKACIN SULF 500 MG/2 ML VIAL?
Since Apr 23, 2025, the NADAC for AMIKACIN SULF 500 MG/2 ML VIAL has ranged from a low of $2.2657 (Jul 22, 2026) to a high of $3.2069 (Aug 13, 2025), with a median of $2.7228 per ML.
Are there cheaper alternatives to AMIKACIN SULF 500 MG/2 ML VIAL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMIKACIN SULF 500 MG/2 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures AMIKACIN SULF 500 MG/2 ML VIAL?
AMIKACIN SULF 500 MG/2 ML VIAL (NDC 63323081502) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.